PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 171 filers reported holding PRECIGEN INC in Q4 2021. The put-call ratio across all filers is 1.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $95,753 | +28.0% | 67,432 | +3.7% | 0.00% | – |
| Q2 2023 | $74,788 | +19.8% | 65,033 | +10.5% | 0.00% | – |
| Q1 2023 | $62,408 | -14.0% | 58,875 | +23.3% | 0.00% | -100.0% |
| Q4 2022 | $72,574 | -28.8% | 47,746 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $102,000 | +61.9% | 47,920 | +1.4% | 0.00% | – |
| Q2 2022 | $63,000 | -36.4% | 47,243 | +0.3% | 0.00% | -100.0% |
| Q1 2022 | $99,000 | -47.1% | 47,089 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $187,000 | -27.8% | 50,403 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $259,000 | -25.4% | 51,912 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $347,000 | +23.5% | 53,145 | +30.3% | 0.00% | 0.0% |
| Q1 2021 | $281,000 | -28.5% | 40,784 | +5.9% | 0.00% | 0.0% |
| Q4 2020 | $393,000 | +182.7% | 38,499 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $139,000 | -31.2% | 39,604 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $202,000 | +38.4% | 40,504 | -5.8% | 0.00% | 0.0% |
| Q1 2020 | $146,000 | – | 42,987 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |